Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
Celgene Corporation - Celgene Reports Record Second Quarter 2009 Operating and Financial Results
Spectrum Pharmaceuticals - FDA Designates Fast Track Status for Apaziquone EOquin® for Bladder Cancer
Breast Cancer - Reports outline breast cancer research from S. Delbarco and colleagues
Cancer - Research from Royal Marsden Hospital yields new data on cancer
Cervical Cancer - Studies from Yale University, Medical Department in the area of cervical cancer published
Chronic Myeloid Leukemia - Scientists at University of Texas report research in chronic myeloid leukemia
Flu Vaccines - Research in the area of flu vaccines reported from A.R. Falsey and colleagues
Gastric Cancer - Findings from N. Baize and co-authors provide new insights into gastric cancer
Gene Therapy - Reports from K. Matthews and co-researchers add new data to research in gene therapy
Hairy Cell Leukemia - Reports from National Institutes of Health describe recent advances in hairy cell leukemia
Life Sciences - Recent findings in life sciences described by F. Moriyasu and colleagues
Life Sciences - Studies from University of Colorado reveal new findings on life sciences
Melanoma - Reports outline melanoma research from R.O. Dillman and colleagues
Ovarian Cancer - Study findings on ovarian cancer are outlined in reports from University of Texas
Perfusion - Study results from University of Perugia broaden understanding of perfusion
Prostate Cancer - New prostate cancer findings from U.N. Vaishampayan and co-researchers published
Schizophrenia - Researchers from University of Texas publish findings in schizophrenia
Solid Cancer - Study results from Oita University provide new insights into solid cancer
Cancer Gene Therapy - Data on cancer gene therapy described by D.L. Lichtenstein et al
Cancer Gene Therapy - Data on cancer gene therapy discussed by J. Nemunaitis and colleagues
Prostate Cancer Risk Factors - Study findings from Duke University broaden understanding of prostate cancer risk factors
AcelRx Pharmaceuticals, Inc. - AcelRx Announces Perfect Performance of Handheld Component of ARX-01 Sufentanil NanoTab PCA System in a Phase 2 Study
Alnylam Pharmaceuticals, Inc. - INSERTING and REPLACING Alnylam and Cubist Announce Complete Data from Phase II Study of ALN-RSV01 in Lung Transplant Patients Naturally Infected with Respiratory Syncytial Virus
Aradigm Corporation - Aradigm Receives FDA Clearance for Phase IIb Clinical Trial of Inhaled Liposomal Ciprofloxacin to Treat Bronchiectasis
Depomed, Inc. - Depomed Provides License for Patents Covering Metformin Extended Release Technology to Merck & Co., Inc.
Diabetes - Oramed Pharmaceuticals Reports Positive Results From a Study of Oral Insulin Capsule on Type 1 Diabetic Patients
FoldRx Pharmaceuticals, Inc. - FoldRx Pharmaceuticals Announces Positive Results from Pivotal Phase II/III Clinical Study of Tafamidis
HIV/AIDS - 96-Week Safety and Efficacy Findings Presented for INTELENCE(TM) (etravirine) As Part of HIV Combination Therapy
HIV/AIDS - Tobira Therapeutics Inc. Announces Phase I Data Demonstrating Pharmacokinetic Properties of TAK-652 for the Treatment of HIV
Human Genome Sciences, Inc. - Human Genome Sciences Announces Second-Quarter 2009 Financial Results and Key Developments
Lupus - Human Genome Sciences and GlaxoSmithKline Announce Positive Phase 3 Study Results for BENLYSTA(TM) in Systemic Lupus Erythematosus
Merck - ISENTRESS® raltegravir, from Merck, was as Effective as Efavirenz at Suppressing HIV Viral Load and Increasing CD4 Cell Counts in Treatment-Naive Patients up to 144 Weeks When Used in Combination Therapy
